This presentation provides a broad overview of the benefits of DTG-containing regimens, the advantages of fixed-dose combination ARVs, and guidance for TLD rollout.
CHAI TLD Product Profile
top of page
A framework to support new product introduction in national health systems
bottom of page
Comments